Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Bertrand Bellier & David Klatzmann. (2013) Virus-like particle-based vaccines against hepatitis C virus infection. Expert Review of Vaccines 12:2, pages 143-154.
Read now
Read now
Mélanie Lambotin, Heidi Barth, Christiane Moog, François Habersetzer, Thomas F Baumert, Françoise Stoll-Keller & Samira Fafi-Kremer. (2012) Challenges for HCV vaccine development in HIV–HCV coinfection. Expert Review of Vaccines 11:7, pages 791-804.
Read now
Read now
Farzin Roohvand & Niloufar Kossari. (2011) Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine design. Expert Opinion on Therapeutic Patents 21:12, pages 1811-1830.
Read now
Read now
Maria Ripoli & Valerio Pazienza. (2011) Impact of HCV genetic differences on pathobiology of disease. Expert Review of Anti-infective Therapy 9:9, pages 747-759.
Read now
Read now
Wikrom Karnsakul, Mary Kay Alford & Kathleen B Schwarz. (2009) Managing pediatric hepatitis C: current and emerging treatment options. Therapeutics and Clinical Risk Management 5, pages 651-660.
Read now
Read now
Articles from other publishers (62)
Rodrigo C. Menezes, Isabella B. B. Ferreira, Gabriela L. Rosier, Klauss Villalva-Serra, Vanessa M. S. Campos, Beatriz B. S. Passos, João Victor S. Argolo, Gabriel C. Santana, Stefania L. Garcia, Hugo N. Pustilnik, Rebeca R. C. Silva, Beatriz Barreto-Duarte, Mariana Araújo-Pereira & Bruno B. Andrade. (2023) Grand challenges in major tropical diseases: Part II. Frontiers in Tropical Diseases 4.
Crossref
Crossref
Radwa Samir Hagag, Morkoss Medhat Fakhry, Ossama Ashraf Ahmed, Shaimaa Abdalaleem Abdalgeleel, Mahasen Aly Radwan & Gina Gamal Naguib. (2022) Assessment of efficacy and safety of two Egyptian protocols for treatment-experienced HCV patients: an observational study. The Egyptian Journal of Internal Medicine 34:1.
Crossref
Crossref
Rebecca Dunn, Aaron Wetten, Stuart McPherson & Mhairi C Donnelly. (2022) Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World Journal of Gastroenterology 28:1, pages 76-95.
Crossref
Crossref
Ali Shayeghpour, Roya Kianfar, Parastoo Hosseini, Mehdi Ajorloo, Sepehr Aghajanian, Mojtaba Hedayat Yaghoobi, Tayebeh Hashempour & Sayed-Hamidreza Mozhgani. (2021) Hepatitis C virus DNA vaccines: a systematic review. Virology Journal 18:1.
Crossref
Crossref
Yi Liu, Kai Wang, Tarik F. Massoud & Ramasamy Paulmurugan. (2020) SARS-CoV-2 Vaccine Development: An Overview and Perspectives. ACS Pharmacology & Translational Science 3:5, pages 844-858.
Crossref
Crossref
. 2020. Mathematical Approaches to Liver Transplantation. Mathematical Approaches to Liver Transplantation
153
168
.
Uyen Ngoc Mui, Christopher T. Haley, Ramya Vangipuram & Stephen K. Tyring. (2019) Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention. Journal of the American Academy of Dermatology 81:1, pages 23-41.
Crossref
Crossref
Noura H Abd Ellah, Hesham M Tawfeek, James John & Helal F Hetta. (2019) Nanomedicine as a future therapeutic approach for Hepatitis C virus. Nanomedicine 14:11, pages 1471-1491.
Crossref
Crossref
Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Alexander Underwood, Dale Christiansen, Linda Earnest-Silveira, Rowena Bull, Joseph Torresi, Eric J. Gowans & Branka Grubor-Bauk. (2019) A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. Frontiers in Immunology 10.
Crossref
Crossref
Elisabetta Loggi, Ranka Vukotic, Fabio Conti, Stefano Gitto & Pietro Andreone. (2018) Gold standard assays for the monitoring of patients with chronic hepatitis C. Future Virology 13:8, pages 529-537.
Crossref
Crossref
J. Magarian Blander. (2018) Regulation of the Cell Biology of Antigen Cross-Presentation. Annual Review of Immunology 36:1, pages 717-753.
Crossref
Crossref
G. Song & H. Vollbrecht. 2017. Translating MicroRNAs to the Clinic. Translating MicroRNAs to the Clinic
93
133
.
Eliah Aronoff-Spencer, A.G. Venkatesh, Alex Sun, Howard Brickner, David Looney & Drew A. Hall. (2016) Detection of Hepatitis C core antibody by dual-affinity yeast chimera and smartphone-based electrochemical sensing. Biosensors and Bioelectronics 86, pages 690-696.
Crossref
Crossref
C S Rollier, E J Verschoor, B E Verstrepen, J A R Drexhage, G Paranhos-Baccala, P Liljeström, G Sutter, L Arribillaga, J J Lasarte, B Bartosch, F-L Cosset, G Inchauspe & J L Heeney. (2016) T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates. Gene Therapy 23:10, pages 753-759.
Crossref
Crossref
F. De Conto, M. C. Medici, F. Ferraglia, F. Pinardi, A. Fazzi, M. C. Arcangeletti, C. Chezzi & A. Calderaro. (2016) Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy. Archives of Virology 161:10, pages 2727-2737.
Crossref
Crossref
Bo-Kyoung Jung, Hye-Ran Kim, Gyu-Nam Park, Guangxiang Luo & Kyung-Soo Chang. (2016) Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a. Journal of Microbiology 54:6, pages 451-458.
Crossref
Crossref
Laszlo Szereday, Matyas Meggyes, Melinda Halasz, Julia Szekeres-Bartho, Alajos Par & Gabriella Par. (2016) Immunological changes in different patient populations with chronic hepatitis C virus infection. World Journal of Gastroenterology 22:20, pages 4848.
Crossref
Crossref
Kouka Saadeldin Abdelwahab. (2016) Status of hepatitis C virus vaccination: Recent update. World Journal of Gastroenterology 22:2, pages 862.
Crossref
Crossref
Nishant K. Jain, Neha Sahni, Ozan S. Kumru, Sangeeta B. Joshi, David B. Volkin & C. Russell Middaugh. (2015) Formulation and stabilization of recombinant protein based virus-like particle vaccines. Advanced Drug Delivery Reviews 93, pages 42-55.
Crossref
Crossref
Subodh Kumar SamratSatish VediShakti SinghWen LiRakesh KumarBabita Agrawal. (2015) Immunization with Recombinant Adenoviral Vectors Expressing HCV Core or F Proteins Leads to T Cells with Reduced Effector Molecules Granzyme B and IFN-γ: A Potential New Strategy for Immune Evasion in HCV Infection. Viral Immunology 28:6, pages 309-324.
Crossref
Crossref
Zhong Zhao, Lilin Zhong, Elizabeth Elrod, Evi Struble, Li Ma, Hailing Yan, Christine Harman, Lu Deng, Maria Luisa Virata-Theimer, Peter Liu, Harvey Alter, Arash Grakoui & Pei Zhang. (2014) A Neutralization Epitope in the Hepatitis C Virus E2 Glycoprotein Interacts with Host Entry Factor CD81. PLoS ONE 9:1, pages e84346.
Crossref
Crossref
Franco M Buonaguro & Luigi BuonaguroBertrand BellierDavid Klatzmann. 2014. Virus-like Particles in Vaccine Development. Virus-like Particles in Vaccine Development
36
49
.
Bo Wen, Yao Deng, Hong Chen, Jie Guan, Xia Chuai, Li Ruan, Wei Kong & Wenjie Tan. (2013) The Novel Replication-defective Vaccinia Virus (Tiantan Strain)–based Hepatitis C Virus Vaccine Induces Robust Immunity in Macaques. Molecular Therapy 21:9, pages 1787-1795.
Crossref
Crossref
Chunqiu Hao. (2013) Development of a dendritic cell vaccine encoding multiple cytotoxic T�lymphocyte epitopes targeting hepatitis�C virus. International Journal of Molecular Medicine.
Crossref
Crossref
Catherine Fauvelle, Quentin Lepiller, Daniel J. Felmlee, Isabel Fofana, François Habersetzer, Françoise Stoll-Keller, Thomas F. Baumert & Samira Fafi-Kremer. (2013) Hepatitis C virus vaccines – Progress and perspectives. Microbial Pathogenesis 58, pages 66-72.
Crossref
Crossref
Reem Al Olaby, Hassan M. Azzazy, Rodney Harris, Brett Chromy, Jost Vielmetter & Rod Balhorn. (2013) Identification of ligands that target the HCV-E2 binding site on CD81. Journal of Computer-Aided Molecular Design 27:4, pages 337-346.
Crossref
Crossref
Christophe Huret, Delphine Desjardins, Mathilde Miyalou, B?atrice Levacher, Martin Amadoudji Zin, Olivia Bonduelle, B?hazine Combadi?re, Charlotte Dalba, David Klatzmann & Bertrand Bellier. (2013) Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Vaccine 31:11, pages 1540-1547.
Crossref
Crossref
Mirjam B. Zeisel, Joachim Lupberger, Isabel Fofana & Thomas F. Baumert. (2013) Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges. Journal of Hepatology 58:2, pages 375-384.
Crossref
Crossref
S.M. Criscione. (2012) May viral (antigen) load be the real crucial tool leading to anergy in a “micro-evolutionary” model of host/virus interaction?. Medical Hypotheses 79:6, pages 774-778.
Crossref
Crossref
Christoph S. Klade, Elisabeth Schuller, Thomas Boehm, Alexander von Gabain & Michael P. Manns. (2012) Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination. Vaccine 30:19, pages 2943-2950.
Crossref
Crossref
Rania A. Tohme, Deborah Holtzman & Scott D. Holmberg. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1105
1112.e4
.
Lynn B. Dustin. 2012. HCV Infection and Cryoglobulinemia. HCV Infection and Cryoglobulinemia
21
36
.
Natalie A. Parlane, Katrin Grage, Jason W. Lee, Bryce M. Buddle, Michel Denis & Bernd H. A. Rehm. (2011) Production of a Particulate Hepatitis C Vaccine Candidate by an Engineered Lactococcus lactis Strain. Applied and Environmental Microbiology 77:24, pages 8516-8522.
Crossref
Crossref
Yoshio Fujita & Hiroaki Taguchi. (2011) Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles. Chemistry Central Journal 5:1.
Crossref
Crossref
Felix Hoppe‐Seyler & Karin Hoppe‐Seyler. (2011) Emerging topics in human tumor virology. International Journal of Cancer 129:6, pages 1289-1299.
Crossref
Crossref
Pierre GarroneAnne-Catherine FluckigerPhilippe E. MangeotEmmanuel GauthierPia Dupeyrot-LacasJimmy MancipArnaud CangialosiIsaure Du ChénéRoger LeGrandIsabelle MangeotDimitri LavilletteBertrand BellierFrançois-Loic CossetFrederic TangyDavid KlatzmannCharlotte Dalba. (2011) A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques. Science Translational Medicine 3:94.
Crossref
Crossref
Li Duan, Pan Lei, Xie Yumei, Xue Xiaoping, Zhao Futao, Ma Li, Wei Xin, Wang Jiuping, Bai Xuefan & Jia Zhansheng. (2011) Prediction and identification‐based prediction of Chinese hepatitis C viral‐specific cytotoxic T lymphocyte epitopes. Journal of Medical Virology 83:8, pages 1315-1320.
Crossref
Crossref
Itziar Echeverria, Alexander Pereboev, Leyre Silva, Aintzane Zabaleta, Jos? Ignacio Riezu-Boj, Marta Bes, Mar?a Cubero, Francisco Borras-Cuesta, Juan Jos? Lasarte, Juan Ignacio Esteban, Jes?s Prieto & Pablo Sarobe. (2011) Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells. Hepatology 54:1, pages 28-37.
Crossref
Crossref
Chiara Porta, Elena Riboldi & Antonio Sica. (2011) Mechanisms linking pathogens-associated inflammation and cancer. Cancer Letters 305:2, pages 250-262.
Crossref
Crossref
Jie Cao, Zhihui Chen, Yanli Ren, Yuan Luo, Mingmei Cao, Wei Lu, Ping Zhao & Zhongtian Qi. (2011) Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice. Vaccine 29:20, pages 3714-3723.
Crossref
Crossref
Kazunori Kawaguchi, Kristina Faulk, Robert H. Purcell & Suzanne U. Emerson. (2011)
Reproduction
In Vitro
of a Quasispecies from a Hepatitis C Virus-Infected Patient and Determination of Factors That Influence Selection of a Dominant Species
. Journal of Virology 85:7, pages 3408-3414.
Crossref
Crossref
Guimei YangShuwen ChenXiangying ZhuShenghua LiangLongding LiuDaming Ren. (2011) A Synthetic Multi-epitope Antigen Enhances Hepatitis C Virus-Specific B- and T-Cell Responses. Viral Immunology 24:2, pages 109-118.
Crossref
Crossref
Angela Dolganiuc & Gyongyi Szabo. (2011) Dendritic cells in hepatitis C infection: can they (help) win the battle?. Journal of Gastroenterology 46:4, pages 432-447.
Crossref
Crossref
Philip Meuleman, Jens Bukh, Lieven Verhoye, Ali Farhoudi, Thomas Vanwolleghem, Richard Y. Wang, Isabelle Desombere, Harvey Alter, Robert H. Purcell & Geert Leroux-Roels. (2011)
In vivo
evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus
. Hepatology 53:3, pages 755-762.
Crossref
Crossref
Ingmar Mederacke & Thomas von Hahn. (2011) Survival of the fittest: Selection of hepatitis C virus variants during liver graft reinfection. Hepatology 53:2, pages 705-708.
Crossref
Crossref
D.J. Irvine & C.M. Jewell. 2011. Comprehensive Biomaterials. Comprehensive Biomaterials
315
332
.
John T. SchillerDouglas R. Lowy. (2010) Vaccines to Prevent Infections by Oncoviruses. Annual Review of Microbiology 64:1, pages 23-41.
Crossref
Crossref
Jarrod Bailey. (2010) An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee Model. Alternatives to Laboratory Animals 38:5, pages 387-418.
Crossref
Crossref
Eleazar Chaib, Maria Cristina França de Oliveira, Flavio Henrique Ferreira Galvão, Felipe Duarte Silva, Luiz Augusto Carneiro D’Albuquerque & Eduardo Massad. (2010) Theoretical impact of an anti-HCV vaccine on the annual number of liver transplantation. Medical Hypotheses 75:3, pages 324-327.
Crossref
Crossref
Indu Kohaar, Alexander Ploss, Evgenia Korol, Kathy Mu, John W. Schoggins, Thomas R. O'Brien, Charles M. Rice & Ludmila Prokunina-Olsson. (2010)
Splicing Diversity of the Human
OCLN
Gene and Its Biological Significance for Hepatitis C Virus Entry
. Journal of Virology 84:14, pages 6987-6994.
Crossref
Crossref
Margaret E. Fairman-Williams & Eckhard Jankowsky. 2010. RNA Helicases. RNA Helicases
168
188
.
K. Yusim, W. Fischer, H. Yoon, J. Thurmond, P. W. Fenimore, G. Lauer, B. Korber & C. Kuiken. (2010) Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity. Journal of General Virology 91:5, pages 1194-1206.
Crossref
Crossref
Christa Firbas, Thomas Boehm, Vera Buerger, Elisabeth Schuller, Nicolas Sabarth, Bernd Jilma & Christoph S. Klade. (2010) Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine. Vaccine 28:12, pages 2397-2407.
Crossref
Crossref
Pilar León Rega. (2010) Vacunas víricas: conceptos básicos, tipos y aplicaciones. FMC - Formación Médica Continuada en Atención Primaria 17:3, pages 113-121.
Crossref
Crossref
Neelam Mohan, Regino P González-Peralta, Tomoo Fujisawa, Mei-Hwei Chang, Solange Heller, Paloma Jara, Deirdre Kelly, Giorgina Mieli-Vergani, Uzma Shah & Karen F Murray. (2010) Chronic Hepatitis C Virus Infection in Children. Journal of Pediatric Gastroenterology & Nutrition 50:2, pages 123-131.
Crossref
Crossref
Maureen A. Cox & Allan J. Zajac. (2010) Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection. Journal of Biomedicine and Biotechnology 2010, pages 1-12.
Crossref
Crossref
Adan C. Jirmo, Richard C. Koya, Bala Sai Sundarasetty, Mudita Pincha, Guann-Yi Yu, Michael Lai, Rakesh Bakshi, Verena Schlaphoff, Jan Grabowski, Georg Behrens, Heiner Wedemeyer & Renata Stripecke. (2010) Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8+ T cell responses. Vaccine 28:4, pages 922-933.
Crossref
Crossref
Bertrand Bellier. (2009) Vaccins d’aujourd’hui et de demain : nouvelles technologies. Revue Francophone des Laboratoires 2009:417, pages 69-77.
Crossref
Crossref
G. Pappas. (2009) Infectious causes of cancer: an evolving educational saga. Clinical Microbiology and Infection 15:11, pages 961-963.
Crossref
Crossref
Shubham Shrivastava, Kavita S. Lole, Anuradha S. Tripathy, Umesh S. Shaligram & Vidya A. Arankalle. (2009) Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach. Vaccine 27:47, pages 6582-6588.
Crossref
Crossref
Cristina Mansilla, Marta Gorraiz, Marta Martinez, Noelia Casares, Laura Arribillaga, Francesc Rudilla, Iciar Echeverria, Jos? Ignacio Riezu-Boj, Pablo Sarobe, Francisco Borr?s-Cuesta, Jes?s Prieto & Juan Jos? Lasarte. (2009) Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein. Journal of Hepatology 51:3, pages 520-527.
Crossref
Crossref
Melissa D. Simek, Wasima Rida, Frances H. Priddy, Pham Pung, Emily Carrow, Dagna S. Laufer, Jennifer K. Lehrman, Mark Boaz, Tony Tarragona-Fiol, George Miiro, Josephine Birungi, Anton Pozniak, Dale A. McPhee, Olivier Manigart, Etienne Karita, André Inwoley, Walter Jaoko, Jack DeHovitz, Linda-Gail Bekker, Punnee Pitisuttithum, Robert Paris, Laura M. Walker, Pascal Poignard, Terri Wrin, Patricia E. Fast, Dennis R. Burton & Wayne C. Koff. (2009) Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm. Journal of Virology 83:14, pages 7337-7348.
Crossref
Crossref